fulvestrant
NDC 25021-471, fulvestrant, injection, solution, from Sagent Pharmaceuticals.
- Product NDC
- 25021-471
- Status
- Listed
- Labeler
- Sagent Pharmaceuticals
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAMUSCULAR
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA211422
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/25021-471 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- FULVESTRANT50 mg/mL
Pharmacologic classes
Estrogen Receptor Antagonist [EPC]; Estrogen Receptor Antagonists [MoA]; Selective Estrogen Receptor Modulators [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 25021-471-66 | 25021047166 | 2 SYRINGE in 1 CARTON (25021-471-66) / 5 mL in 1 SYRINGE |
| 25021-471-74 | 25021047174 | 2 SYRINGE in 1 CARTON (25021-471-74) / 5 mL in 1 SYRINGE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels?ndc=25021-471Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=25021-471
Use it
Look up 25021-471 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/25021-471 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 25021-471. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.